Standardization Platform on Age and Sex as Biological Variables – Phase 2
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Wednesday 2nd, October 2019
External Deadline: Thursday 8th, October 2020
Description
BY INVITATION ONLY
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them.
The overarching goal of this initiative, which is part of CIHR Institute of Gender and Health (IGH) greater Sex and Gender Science Strategy, is to support the establishment of a multidisciplinary platform that includes researchers with expertise in studying sex and age as biological variables in basic science across different levels of analysis (i.e., cells, tissues, and animals). This platform will identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.
Research Areas
The platform is expected to address three key components:
- 1. Methods and Materials: Create an inventory of best practices, harmonization and standardization processes to study sex and age as biological variables for the basic science community, including procedures and materials;
- 2. Training: Build capacity by providing specialized training and learning opportunities for Canadian researchers (e.g., webinars, hotline, interactive modules, coaching, visiting scholars, wet laboratory training); and
- 3. Knowledge Translation: Promote the platform, its best practices, services offered and tools developed across Canada and internationally.
- .
- Application Process – Phase 2 (by invitation): The second phase will support a full application for a single platform team over four years, to create, teach and disseminate the best practices including standard operating procedures for the integration of sex and age as variables in basic cellular, tissue, and animal preclinical research.
For additional information see Research Net